Literature DB >> 14769484

The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders.

Tim E Cullingford1.   

Abstract

This review outlines the molecular sensors that reprogram cellular metabolism in response to the ketogenic diet (KD). Special emphasis is placed on the fasting-, fatty acid- and drug-activated transcription factor, peroxisome proliferator-activated receptor alpha (PPARalpha). The KD causes a switch to ketogenesis that is coordinated with an array of changes in cellular lipid, amino acid, carbohydrate and inflammatory pathways. The role of both liver and brain PPARalpha in mediating such changes will be examined, with special reference to the anti-epileptic effects not only of the KD but a range of synthetic anti-epileptic drugs such as valproate. Finally, the implications of the KD and activated brain PPARalpha will be discussed in the context of their potential involvement in a range of disorders of neuro-degeneration and neuro-inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769484     DOI: 10.1016/j.plefa.2003.09.008

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  38 in total

1.  Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.

Authors:  Chris J Reisenauer; Dhaval P Bhatt; Dane J Mitteness; Evan R Slanczka; Heidi M Gienger; John A Watt; Thad A Rosenberger
Journal:  J Neurochem       Date:  2011-02-24       Impact factor: 5.372

2.  A Caenorhabditis elegans nutrient response system partially dependent on nuclear receptor NHR-49.

Authors:  Marc R Van Gilst; Haralambos Hadjivassiliou; Keith R Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 3.  State of the ketogenic diet(s) in epilepsy.

Authors:  Jennifer Huffman; Eric H Kossoff
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 4.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

5.  Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models.

Authors:  Carl E Stafstrom; Jeffrey C Ockuly; Lauren Murphree; Matthew T Valley; Avtar Roopra; Thomas P Sutula
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

6.  Hibernation reduces cellular damage caused by warm hepatic ischemia-reperfusion in ground squirrels.

Authors:  Jessica P Otis; Amanda C Pike; Jose R Torrealba; Hannah V Carey
Journal:  J Comp Physiol B       Date:  2017-01-31       Impact factor: 2.200

Review 7.  Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.

Authors:  José Iglesias; Ludis Morales; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.590

8.  Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.

Authors:  Timothy A Simeone; Stephanie A Matthews; Kaeli K Samson; Kristina A Simeone
Journal:  Exp Neurol       Date:  2016-08-12       Impact factor: 5.330

9.  The ketogenic diet has no effect on the expression of spike-and-wave discharges and nutrient transporters in genetic absence epilepsy rats from Strasbourg.

Authors:  Astrid Nehlig; Franck Dufour; Marianne Klinger; Lisa B Willing; Ian A Simpson; Susan J Vannucci
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

10.  Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.